Mylan NV (MYL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Mylan NV (MYL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011020
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, cardiovascular, central nervous systems, infectious disease, oncology, anesthesia and others. Mylan sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The company has research and development facilities in the US, Canada, the UK, Ireland, Italy, Germany, India and Japan. Mylan is headquartered in Hatfield, Hertfordshire, the UK.

Mylan NV (MYL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mylan NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Mylan NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Mylan NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Mylan NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Mylan NV, Medical Equipment, Deal Details 11
Asset Purchase 11
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 11
Venture Financing 13
Zyomyx Raises US$6 Million In First Closing Of Series 2 Preferred Financing 13
Partnerships 14
UDL Labs Enters Into Licensing Agreement With Humeca 14
Mylan Enters Into Distribution Agreement With Zyomyx For CD4 T-Cell Count Test 15
Phosphagenics Enters Into Licensing Agreement With Agila Specialties For TPM Technology 17
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 18
Debt Offering 19
Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 19
Mylan Raises USD1 Billion in Private Placement of 5.25% Notes Due 2046 20
Mylan Raises USD2.25 Billion in Private Placement of 3.95% Notes Due 2026 21
Mylan Raises USD2.25 Billion in Private Placement of 3.15% Notes Due 2021 22
Mylan Raises USD1 Billion in Private Placement of 2.5% Notes Due 2019 23
Mylan NV – Key Competitors 24
Mylan NV – Key Employees 25
Mylan NV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 33
Financial Announcements 33
Nov 06, 2017: Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance 33
Aug 09, 2017: Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance 35
May 10, 2017: Mylan Reports First Quarter 2017 Results 39
Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 41
Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 43
Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 47
Corporate Communications 50
Sep 13, 2017: Mylan Names Dennis Zeleny as Chief Human Relations Officer 50
May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 51
Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 52
Legal and Regulatory 53
Nov 10, 2017: Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange 53
Oct 31, 2017: Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint 54
Product News 55
03/09/2016: TGA issues safety alert about EpiPen Adrenaline Auto-injector 55
Other Significant Developments 56
Mar 08, 2016: Mylan Health Hackathon to Focus on Delivering Better Health for a Better World 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Mylan NV, Medical Equipment, Key Facts, 2016 2
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Mylan NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Mylan NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Mylan NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Mylan NV, Deals By Market, 2011 to YTD 2017 9
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 11
Zyomyx Raises US$6 Million In First Closing Of Series 2 Preferred Financing 13
UDL Labs Enters Into Licensing Agreement With Humeca 14
Mylan Enters Into Distribution Agreement With Zyomyx For CD4 T-Cell Count Test 15
Phosphagenics Enters Into Licensing Agreement With Agila Specialties For TPM Technology 17
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 18
Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 19
Mylan Raises USD1 Billion in Private Placement of 5.25% Notes Due 2046 20
Mylan Raises USD2.25 Billion in Private Placement of 3.95% Notes Due 2026 21
Mylan Raises USD2.25 Billion in Private Placement of 3.15% Notes Due 2021 22
Mylan Raises USD1 Billion in Private Placement of 2.5% Notes Due 2019 23
Mylan NV, Key Competitors 24
Mylan NV, Key Employees 25
Mylan NV, Other Locations 26
Mylan NV, Subsidiaries 27

★海外企業調査レポート[Mylan NV (MYL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Westpac Banking Corporation:企業のM&A・事業提携・投資動向
    Westpac Banking Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westpac Banking Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Purdue Pharma L.P.:企業の戦略・SWOT・財務情報
    Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report Summary Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Honda Motor Co., Ltd.:企業の戦略・SWOT・財務情報
    Honda Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Honda Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • Progressive Building Society:企業の戦略・SWOT・財務情報
    Progressive Building Society - Strategy, SWOT and Corporate Finance Report Summary Progressive Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • LeadFX Inc.:企業のM&A・事業提携・投資動向
    LeadFX Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LeadFX Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • JGC Corp (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corp (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power genera …
  • CANbridge Life Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Canbridge Life Sciences Ltd (Canbridge) is a biopharmaceutical company that offers development and commercialization of specialty healthcare products. The company’s pipeline products include CAN-008, an antibody-like CD95 receptor and Fc-fusion protein used to reduce cancer-cell migration in …
  • OpGen Inc (OPGN):企業の財務・戦略的SWOT分析
    OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KPS AG (KSC):企業の財務・戦略的SWOT分析
    Summary Kps AG (Kps) is a technology company that offers e-commerce and digital marketing services. The company offers consulting services in the areas of business transformation and process optimization. It offers e-business, wholesale, retail, manufacturing, supply chain management, logistics, ser …
  • Steris Plc (STE):製薬・医療:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …
  • Rockefeller University-製薬・医療分野:企業M&A・提携分析
    Summary Rockefeller University (Rockefeller) is a biomedical research university that provides graduate and postdoctoral educational programs. The university offers various educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics. It conducts clinical studies i …
  • FGL Sports Ltd. :企業の戦略・SWOT・財務情報
    FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report Summary FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ReShape Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • Loblaw Companies Limited:企業の戦略・SWOT・財務情報
    Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report Summary Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆